Portage launches Tarus` solid tumor portfolio into new offshoot
06 Jan 2025 //
FIERCE BIOTECH
Tarus receives clearance from the FDA to initiate clinical trial of TT-4
27 May 2021 //
BIOSPACE
Tarus Therapeutics Seeks To Initiate Clinical Trial of TT-4 (A2BR Antagonist)
28 Apr 2021 //
BIOSPACE